IP Library Assignment 064463/0709
Patent Assignment
Reel/Frame 064463/0709

Termination and Release of Intellectual Property Security Agreement Recorded at Reel 061179/Frame 0202

Recorded: 2023-08-01 Pages: 12
Assignor
SLR INVESTMENT CORP.
Executed: 2023-07-31
Assignees
SPECTRUM PHARMACEUTICALS, INC.
2 ATLANTIC AVENUE, 6TH FLOOR, PILOT HOUSE - LEWIS WHARF, BOSTON, MASSACHUSETTS, 02110
ALLOS THERAPEUTICS, INC.
11080 CIRCLE POINT ROAD, SUITE 200, WESTMINSTER, COLORADO, 80020
TALON THERAPEUTICS, INC.
7000 SHORELINE COURT, SUITE 370, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (26)
Inhibitors of Mutant Family Tyrosine-Kinases
Application: 16/757,072 →
Publication: US US20200261455A1
Novel Methods of Treating Neutorpenia Using G-Csf Protein Complex
Application: 16/996,635 →
Publication: US US20210008166A1
Combination of Poziotinib with Cytotoxic Agent and/or Other Molecularly Targeted Agent and Use Thereof
Application: 17/250,258 →
Publication: US US20210145834A1
Poziotinib Combinations with an Anti-HER1, HER2 or HER4 Antibody and Methods of Use Thereof
Application: 17/250,259 →
Publication: US US20210260064A1
Kits and Methods for Treating Cancers
Application: 17/275,290 →
Publication: US US20220040180A1
Crystalline Forms of a Quinazoline Compound and Its Hydrochloride Salts
Application: 17/275,382 →
Publication: US US20220056011A1
Novel Quinazoline Egfr Inhibitors
Application: 17/278,397 →
Publication: US US20210353627A1
Methods of Treating Chemotherapy Induced Neutropenia Using Fixed Doses of Eflapegrastim
Application: 17/374,302 →
Publication: US US20220016212A1
Methods of Treatment Using G-CSF Protein Complex
Application: 17/586,872 →
Publication: US US20220153799A1
Poziotinib Combination with VEGFR2 Inhibitors and Methods of Use Thereof
Application: 17/637,304 →
Publication: US US20220296598A1
Methods of Treatment Using G-Csf Protein Complex
Application: 17/781,639 →
Publication: US US20230027238A1
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Solid Tumors
Patent: 8,217,010 →
Application: 11/360,236 →
Publication: US US20060211617A1
Sensitization of Tumor Cells to Radiation Therapy Through the Administration of Endothelin Agonists
Patent: 8,394,757 →
Application: 11/845,648 →
Publication: US US20080318846A1
Methods and Compositions for Contributing to the Treatment of Cancers
Patent: 8,026,216 →
Application: 12/101,008 →
Publication: US US20080253994A1
Formulations of Vitamin K Analogs for Topical Use
Patent: 8,815,953 →
Application: 12/381,467 →
Publication: US US20090234022A1
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Patent: 8,030,278 →
Application: 12/390,376 →
Publication: US US20090155206A1
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Patent: 8,440,620 →
Application: 13/220,358 →
Publication: US US20110315575A1
Methods and Compositions for Contributing to the Treatment of Cancers
Patent: 8,349,802 →
Application: 13/220,373 →
Publication: US US20110311481A1
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Solid Tumors
Patent: 8,703,709 →
Application: 13/491,408 →
Publication: US US20120245105A1
Methods and Compositions for Contributing to the Treatment of Cancers
Patent: 8,642,026 →
Application: 13/707,807 →
Publication: US US20130101552A1
Methods, Compositions and Articles of Manufacture for Contributing to the Treatment of Cancers
Patent: 8,729,023 →
Application: 13/711,519 →
Publication: US US20130102543A1
Sensitization of Tumor Cells to Radiation Therapy Through Administration of Endothelin Agonists
Patent: 8,957,014 →
Application: 13/761,043 →
Publication: US US20130150649A1
Treatment of Primary and Metastatic Carcinoma
Patent: 9,308,235 →
Application: 13/890,938 →
Publication: US US20130338079A1
Treatment of Primary and Metastatic Carcinoma
Application: 15/061,821 →
Publication: US US20160287660A1
Compositions Comprising Disodium Levofolinate
Application: 16/257,684 →
Methods of Treatment Using G-Csf Protein Complex
Application: 16/428,351 →
Publication: US US20200377567A1
Related Assignments (17)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jun 8, 2012
From: GULATI, ANIL
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 028347/0431 →
Assignment of Assignor's Interest Aug 1, 2012
From: GULATI, ANIL
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
Reel/Frame 028703/0458 →
Notice of Grant of Security Interest in Patents Sep 20, 2012
From: SPECTRUM PHARMACEUTICALS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 029017/0877 →
Notice of Grant of Security Interest in Patents Sep 23, 2013
From: TALON THERAPEUTICS, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 031263/0934 →
Release of Security Interest Jan 17, 2014
From: BANK OF MERICA, N.A.
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 031996/0565 →
Release of Security Interest Jan 17, 2014
From: BANK OF AMERICA, N.A.
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 031995/0892 →
Assignment of Assignor's Interest Jan 21, 2021
From: CHOI, JAE HYUK; KIM, EUN JUNG; KIM, YU YON; LEE, GYU HYAN
To: HANMI PHARM CO., LTD.
Reel/Frame 054989/0437 →
Assignment of Assignor's Interest Mar 15, 2021
From: BAEK, JONG OUK; KIM, CHEOL HEE; HA, TAE HEE; SUH, KWEEHYUN
To: HANMI PHARMACEUTICAL CO., LTD.
Reel/Frame 055594/0716 →
Assignment of Assignor's Interest Apr 19, 2021
From: KIM, HEE CHEOL
To: HANMI PHARMACEUTICAL CO., LTD.
Reel/Frame 055955/0327 →
Assignment of Assignor's Interest May 24, 2021
From: REDDY, GURU
To: SPECTRUM PHARMACEUTICALS
Reel/Frame 056331/0643 →
Security Interest Sep 22, 2022
From: SPECTRUM PHARMACEUTICALS, INC.; ALLOS THERAPEUTICS, INC.; TALON THERAPEUTICS, INC.
To: SLR INVESTMENT CORP., AS COLLATERAL AGENT
Reel/Frame 061179/0202 →
Assignment of Assignor's Interest Oct 5, 2022
From: BHAT, GAJANAN; CHAWLA, SHANTA
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 061313/0480 →
Assignment of Assignor's Interest Oct 21, 2022
From: CHATURVEDULA, PRASAD V.; KOLLI, PRASAD, PH.D
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 061491/0272 →
Assignment of Assignor's Interest Sep 1, 2023
From: REDDY, GURU
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 064770/0747 →
Assignment of Assignor's Interest Nov 11, 2025
From: REDDY, GURU
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 072864/0963 →
Assignment of Assignor's Interest Nov 12, 2025
From: BARRETT, JOHN A.; LAKSHMIKANTHAN, SRIBALAJI
To: SPECTRUM PHARMACEUTICALS, INC.
Reel/Frame 072881/0226 →
Assignment of Assignor's Interest May 1, 2026
From: SPECTRUM PHARMACEUTICALS, INC.
To: ASSERTIO SPECIALTY PHARMACEUTICALS, LLC
Reel/Frame 074542/0184 →